Gastrointestinal Dysfunctions in Parkinson’s Disease: Symptoms and Treatments

Poirier, Andrée-Anne, Aubé, Benoit, Côté, Mélissa, Morin, Nicolas, Di Paolo, Thérèse, Soulet, Denis·2016·Parkinson s Disease
DOI 10.1155/2016/6762528

Cites (217)

Items 201–217 of 217

  1. Outcomes of submandibular duct re-implantation for sialorrhoea
    A. Panarese, Sudip Ghosh, D. Hodgson, J. McEwan, P. D. Bull · 2001 · Clinical Otolaryngology
  2. Impact of Progression of Parkinson’s Disease on Drooling in Various Ethnic Groups
    Abdul Qayyum Rana, Muhammad Saad Yousuf, Naeem Awan, Abdul Fattah · 2012 · European Neurology
  3. Adjunctive Quetiapine Decreases Symptoms of Tardive Dyskinesia in a Patient Taking Risperidone
    Matthew W. Nelson, Rhonda R. Reynolds, Deanna L. Kelly, Robert R. Conley · 2003 · Clinical Neuropharmacology
  4. [Treatment of sialorrhea in Parkinson's disease patients with clonidine. Double-blind, comparative study with placebo].
    Marcos Serrano‐Dueñas · 2003 · PubMed
  5. The impact of deep brain stimulation on the nonmotor symptoms of Parkinson’s disease
    Keyoumars Ashkan, Michael Samuel, Prashanth Reddy, К. Ray Chaudhuri · 2012 · Journal of Neural Transmission
  6. Short‐term effects of magnetic sacral dermatome stimulation for idiopathic slow transit constipation: Sham‐controlled, cross‐over pilot study
    Kwang Jae Lee, Jin Hong Kim, Sung Won Cho · 2006 · Journal of Gastroenterology and Hepatology
  7. Treatment of recurrent sigmoid volvulus in Parkinson's disease by percutaneous endoscopic colostomy
    Susan Toebosch · 2012 · World Journal of Gastroenterology
  8. Neostigmine for Refractory Constipation in Advanced Cancer Patients
    Álvaro Sanz Rubiales, Silvia Hernansanz, Celia Gutiérrez, María Luisa del Valle, Luis Alberto Flores · 2006 · Journal of Pain and Symptom Management
  9. Dopamine Neurotransmission and Treatments for Parkinson's Disease in the Molecular Biology Era
    Norio Ogawa · 2008 · European Neurology
  10. IN DEMENTIA WITH LEWY BODIES, BRAAK STAGE DETERMINES PHENOTYPE, NOT LEWY BODY DISTRIBUTION
    K. A. Jellinger · 2008 · Neurology
  11. Clinical implications of irregular ADMET properties with levodopa and other antiparkinson's drugs
    Lívia Dézsi, László Vécsei · 2014 · Expert Opinion on Drug Metabolism & Toxicology
  12. Neurodegenerative Disorders
    Thomas C. Neylan · 2002 · Journal of Neuropsychiatry
  13. Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome
    Ruchit Sood, Alexander Charles Ford · 2013 · Therapeutic Advances in Chronic Disease
  14. Influence of 5-HT4receptor activation on acetylcholine release in human large intestine with endometriosis
    Romain Adelin Lefebvre, Simone Ferrero, Inge Van Colen, Ingeborg Dhaese, Giovanni Bruno Camerini, Ezio Fulcheri, Valentino Remorgida · 2009 · Neurogastroenterology & Motility
  15. Effects of long-term infusions of dopa and carbidopa on renin and steroid secretion in the rat.
    G Inglis, C.J. Kenyon · 1992 · Endocrinology
  16. Effects of long-term infusions of dopa and carbidopa on renin and steroid secretion in the rat
    G Inglis · 1992 · Endocrinology
  17. Poster session 5: Nonmotor aspects of movement disorders, clinical, Parkinsonism
    2002 · Movement Disorders